SLU-PP-332 research, identity and evidence limits
SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors. Mouse studies examine exercise-like metabolic responses; it is not a peptide or a proven exercise replacement.
Identity and formulation
The targeted ERR-alpha, ERR-beta and ERR-gamma receptors are estrogen-related orphan nuclear receptors. The name should not be confused with a claim that this compound is estrogen or an estrogen replacement.
The original investigators developed SLU-PP-332 as an experimental chemical tool with activity at all three ERR subtypes.
What the studies show
Two directly relevant papers evaluate muscle-cell mechanisms and mouse endurance or metabolic outcomes. They support investigation of ERR signaling. They do not establish human weight-loss efficacy, a usable oral regimen or protection against the broad risks that exercise influences.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
Skeletal-muscle cell studies and experiments in mice Reading scope: PubMed bibliographic record and abstract |
SLU-PP-332 increased cell respiration and oxidative muscle-fiber features, and improved endurance in mice through an ERR-alpha-dependent program. | Exercise-related gene expression and treadmill performance in mice do not establish human clinical benefit. |
| A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Diet-induced obese and ob/ob mouse models Reading scope: PubMed bibliographic record and abstract |
Treatment changed energy expenditure and fat oxidation and reduced fat accumulation, with improved insulin sensitivity in the models studied. | These are preclinical metabolic outcomes; obesity-model effects cannot define a safe human dose or expected weight loss. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
How to interpret the findings
Exercise mimetic is a research description of selected responses. Exercise also affects cardiovascular, musculoskeletal and behavioral systems not validated by these experiments.
A human development program would need exposure, target engagement, toxicology and controlled clinical outcomes. Similar gene-expression patterns alone would not be enough to establish comparable health benefits.
Safety context
The two mouse papers do not characterize long-term human cardiovascular, metabolic or reproductive risks. The lack of a clinical safety profile must not be rewritten as absence of adverse effects.
Study exposure and units
Keep the original animal route, exposure and experimental conditions separate from human dosing. A mouse metabolic study does not establish oral bioavailability or a clinical schedule.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Product identity and report checks
Seek chemical identity and assay information appropriate to the small molecule, including the stated form and relevant impurities. A peptide-style certificate or a label alone does not establish the correct research material.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Common questions
Is SLU-PP-332 a peptide?
No. It is a synthetic small molecule, so peptide sequence, peptide purity and peptide dosing assumptions are inappropriate starting points.
Can it replace training?
The reviewed experiments do not establish that. Improved mouse endurance and altered energy metabolism are much narrower findings than the benefits of physical activity in people.
Do the studies validate pills sold under this name?
No. A commercial route, formulation and identity require their own evidence. The animal experiments do not authenticate a vendor product.
Sources
- Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. (PubMed bibliographic record and abstract)
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome. (PubMed bibliographic record and abstract)